-The Business Standard The Nobel laureate says neglecting children is not only unjust but also an economic blunder Nobel laureate Amartya Sen said the National Food Security Bill needs to be strengthened to include children’s entitlements. According to him, the Bill, in the current form, neglects children. He pointed out that there are powerful lobbies for diesel and LPG subsidies, and even for exemptions of custom duties on gold imports. However, nobody is...

-The Hindu Business Line Nobel Laureate Amartya Sen on Friday said that the tabling of the Food Security Bill in Parliament was “a big achievement”, but also drew attention to its shortcomings and called for it to be strengthened, especially with regard to child entitlements. He was participating in a panel discussion on ‘Hunger and Nutrition: Time to Act’ held at IIT- Delhi, with Montek Singh Ahluwalia, Deputy Chairman, Planning Commission, Shantha...

-The Hindu Even as the Centre hopes to introduce and pass the National Food Security Bill in the coming budget session of Parliament, several States have expressed reservations on the Bill. At a consultation meeting of State Food Ministers here to evolve a consensus on the recommendations of the Parliamentary Standing Committee to which the government Bill was referred on Wednesday, many States differed on crucial provisions, particularly the ones relating to...

-The Economic Times Cash transfer in various forms has been used in many countries to target support to the poor and achieve social objectives. In India, its introduction has generated more passion than rational debate. The scheme is not a magic bullet, but if properly implemented and targeted, cash transfer is a very sensible instrument of social assistance. In India, the rationale for introducing the scheme seems to be to check...

-The Hindu The efforts to win the war against tuberculosis using an efficacious vaccine candidate (MVA85A) in infants aged 4-6 months have returned a disappointing verdict despite showing great promise in pre-clinical trials. Though it fulfilled the primary objective of safety and despite inducing modest immune responses, the efficacy of the vaccine was just 17.3 per cent, and hence considered insufficient to protect the infants against TB, notes a paper published...